Cargando…

Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model

SCOPE: A major downside of oral immunotherapy (OIT) for food allergy is the risk of severe side effects. Non‐digestible short‐ and long‐chain fructo‐oligosaccharides (scFOS/lcFOS) reduce allergy development in murine models. Therefore, it is hypothesized that scFOS/lcFOS can also support the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagenaar, Laura, Bol‐Schoenmakers, Marianne, Giustarini, Giulio, Vonk, Marlotte M., van Esch, Betty C.A.M., Knippels, Leon M.J., Garssen, Johan, Smit, Joost J., Pieters, Raymond H.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766954/ https://www.ncbi.nlm.nih.gov/pubmed/30102006 http://dx.doi.org/10.1002/mnfr.201800369

Ejemplares similares

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017)

Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
por: Vonk, Marlotte M., et al.
Publicado: (2017)

A network-based approach for identifying suitable biomarkers for oral immunotherapy of food allergy
por: van Bilsen, Jolanda H. M., et al.
Publicado: (2019)

IL-10 Receptor or TGF-β Neutralization Abrogates the Protective Effect of a Specific Nondigestible Oligosaccharide Mixture in Cow-Milk-Allergic Mice
por: Kerperien, JoAnn, et al.
Publicado: (2018)

Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow's Milk Allergic Mice
por: Vonk, Marlotte M., et al.
Publicado: (2019)

Metabolic fate of newly developed nondigestible oligosaccharide, maltobionic acid, in rats and humans
por: Tanabe, Kenichi, et al.
Publicado: (2020)

Combined Exposure of Activated Intestinal Epithelial Cells to Nondigestible Oligosaccharides and CpG-ODN Suppresses Th2-Associated CCL22 Release While Enhancing Galectin-9, TGFβ, and Th1 Polarization
por: Overbeek, Saskia A., et al.
Publicado: (2019)

The individual role of peanut proteins Ara h1, 2, 3 and 6 in peanut allergy
por: Joost, Smit, et al.
Publicado: (2011)

AhR pathway activation prevents food allergy in mice partly by preserving CD25-positive Tregs in the thymus
por: Pieters, R, et al.
Publicado: (2013)

Multicenter validation of a mouse model for cow's milk allergy to assess the allergenicity of hydrolysed cow's milk based infant formulae
por: van Esch, BCAM, et al.
Publicado: (2013)

Gastrointestinal Effects and Tolerance of Nondigestible Carbohydrate Consumption
por: Mysonhimer, Annemarie R, et al.
Publicado: (2022)

Perspective: Assessing Tolerance to Nondigestible Carbohydrate Consumption
por: Holscher, Hannah D, et al.
Publicado: (2022)

Dietary Intervention with β-Lactoglobulin-Derived Peptides and a Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates the Prevention of Whey-Induced Allergy in Mice by Supporting a Tolerance-Prone Immune Environment
por: Kostadinova, Atanaska I., et al.
Publicado: (2017)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Heterogeneous responses and cross reactivity between the major peanut allergens Ara h 1, 2,3 and 6 in a mouse model for peanut allergy
por: Smit, Joost J, et al.
Publicado: (2015)

Indole-3-carbinol, a plant nutrient and AhR-Ligand precursor, supports oral tolerance against OVA and improves peanut allergy symptoms in mice
por: Hammerschmidt-Kamper, Christiane, et al.
Publicado: (2017)

A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides
por: Kostadinova, Atanaska I., et al.
Publicado: (2017)

Role of Cellular Immunity in Cow's Milk Allergy: Pathogenesis, Tolerance Induction, and Beyond
por: Jo, Juandy, et al.
Publicado: (2014)

Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients
por: Hayen, Simone M., et al.
Publicado: (2018)

Fructo-Oligosaccharides Modify Human DC Maturation and Peanut-Induced Autologous T-Cell Response of Allergic Patients In Vitro
por: Hayen, Simone M., et al.
Publicado: (2021)

Peanut Allergy: An Overview
por: Al-Ahmed, Nasser, et al.
Publicado: (2008)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Perspective: Physiologic Importance of Short-Chain Fatty Acids from Nondigestible Carbohydrate Fermentation
por: Alexander, Celeste, et al.
Publicado: (2019)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

In Vitro Evidence for Immune-Modulatory Properties of Non-Digestible Oligosaccharides: Direct Effect on Human Monocyte Derived Dendritic Cells
por: Lehmann, Sarah, et al.
Publicado: (2015)

Developing Therapies for Peanut Allergy
por: Bublin, Merima, et al.
Publicado: (2014)

Selenium Modulates the Allergic Response to Whey Protein in a Mouse Model for Cow’s Milk Allergy
por: Zhao, Xiaoli, et al.
Publicado: (2021)

The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity
por: McCann, William, et al.
Publicado: (2021)

Treatment with synthetic β-lactoglobulin peptides can prevent clinical symptoms in a mouse model for cow’s milk allergy
por: Meulenbroek, L, et al.
Publicado: (2013)

P22 – Set-up and validation of a mouse model for food-allergy induced atopic dermatitis
por: Rijnierse, Anneke, et al.
Publicado: (2014)

Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model
por: Liu, Manman, et al.
Publicado: (2022)

Exposure of Intestinal Epithelial Cells to Short- and Long-Chain Fructo-Oligosaccharides and CpG Oligodeoxynucleotides Enhances Peanut-Specific T Helper 1 Polarization
por: Hayen, Simone M., et al.
Publicado: (2018)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

Peanut, soy, and emerging legume allergy in Canada
por: Cosyns, Josie C.E., et al.
Publicado: (2022)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Adhesion molecules in experimental peanut allergy
por: Bennett, Jami, et al.
Publicado: (2010)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

sIgE to peanut components does not accurately predict the severity of allergy in subjects suspected of peanut allergy
por: Klemans, Rob, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tmt43vih86is0ukm52p64lbsfh